evid
suggest
atop
individu
may
predispos
sever
rhinovir
cold
coupl
worsen
exist
airway
diseas
asthma
role
atopi
ige
level
well
relationship
clinic
diseas
express
defin
hypothes
allerg
diathesi
modul
rhinovir
cold
initi
studi
normal
atop
asthmat
subject
employ
experiment
rhinovir
infect
measur
symptom
score
viral
shed
cultur
albumin
nasal
wash
serolog
respons
twentytwo
subject
normal
atop
atop
asthmat
particip
inocul
human
rhinoviru
serotyp
hrv
measur
neutral
antibodi
viral
cultur
perform
screen
preinocul
cold
week
convalesc
daili
symptom
note
nasal
wash
done
ige
measur
atopi
diagnos
skin
test
seventeen
volunt
develop
clinic
cold
assess
symptom
score
viru
shed
demonstr
posit
cultur
subject
fourfold
higher
seroconvers
occur
neutral
hrv
antibodi
develop
unexpectedli
subject
screen
inocul
presenc
absenc
preinocul
antibodi
determin
subsequ
sever
cold
normal
atop
subject
atop
antibodi
posit
individu
develop
sever
clinic
cold
independ
preinocul
antibodi
contrast
normal
subject
develop
mild
cold
presenc
neutral
antibodi
p
atop
normal
antibodi
neg
subject
develop
sever
cold
differenti
respons
match
nasal
wash
albumin
level
significantli
increas
cold
atop
normal
volunt
preinocul
antibodi
level
ige
correl
sever
clinic
diseas
viral
shed
studi
hrv
diseas
atop
subject
suggest
heighten
suscept
detriment
effect
cold
addit
studi
need
clarifi
relev
mechan
although
common
cold
preval
ill
human
inform
pathogenesi
symptom
relationship
infect
atop
diseas
asthma
difficult
obtain
recent
studi
implic
human
rhinovirus
hrv
major
factor
associ
exacerb
asthma
children
view
base
studi
employ
sensit
polymeras
chain
reaction
diagnosi
correspond
dr
p
g
bardin
univers
medicin
centr
block
southampton
gener
hospit
tremona
road
southampton
uk
investig
suggest
worsen
atop
diseas
may
mediat
way
increas
sensit
atop
individu
manifest
augment
airway
respons
induct
late
asthmat
reaction
hrv
atop
subject
may
thu
intrins
prone
develop
sever
cold
symptom
includ
chest
symptom
earli
investig
epidemiolog
spread
serolog
respons
infect
hrv
conduct
studi
employ
human
experiment
diseas
volunt
recent
model
expand
investig
interrelationship
hrv
allerg
diseas
import
aspect
interact
atop
statu
symptom
score
viral
shed
serolog
respons
evalu
definit
link
establish
controversi
remain
whether
atop
individu
suscept
consequ
rhinovir
infect
postul
clinic
express
rhinovir
cold
modul
allerg
statu
individu
report
detail
develop
programm
induct
hrv
serotyp
hrv
cold
adult
volunt
evalu
clinic
sever
infect
serolog
respons
associ
factor
may
determin
express
diseas
normal
atop
volunt
studi
conduct
normal
nonsmok
volunt
nonsmok
atop
subject
six
asthmat
measur
antibodi
hrv
serum
dilut
initi
screen
asthmat
patient
control
use
requir
baselin
fevi
predict
asthma
defin
pef
variabl
histamin
hyperrespons
mgml
subject
gave
inform
consent
enrol
studi
studi
approv
southampton
hospit
univers
ethic
subcommitte
subject
studi
three
phase
phase
baselin
observ
conduct
day
prior
viral
inocul
includ
skinprick
test
common
allergen
total
serum
ige
serum
repeat
neutral
antibodi
nasal
wash
viral
cultur
took
place
infecti
diseas
unit
idu
southampton
gener
hospit
subject
isol
day
experiment
hrv
infect
phase
follow
hrv
inocul
subject
daili
nasal
wash
assess
symptom
repeat
serolog
phase
investig
repeat
week
undertaken
serum
obtain
month
prior
inocul
volunt
admiss
studi
screen
well
day
prior
inocul
hrv
day
experiment
diseas
day
admiss
final
week
later
test
could
repeat
three
volunt
move
elsewher
uk
oversea
microneutr
test
well
tissu
cultur
plate
use
briefli
serial
doubl
dilut
sera
ml
made
diluent
hela
mainten
fetal
calf
serum
ad
equal
volum
viru
concentr
tissu
cultur
infect
ml
volum
ml
incub
room
temperatur
h
serial
dilut
ad
freshli
strip
hela
cell
x
cellsml
plate
incub
appropri
serum
cell
viral
control
includ
cytopath
effect
cpe
read
microscop
day
incub
confirm
fix
stain
plate
assay
perform
duplic
assess
atop
statu
skinprick
test
test
perform
use
standard
set
allergen
dermatophagoidespteronyssinu
mix
grass
pollen
cat
dander
dog
hair
feather
candida
alhican
aspergillu
fumigatu
histamin
use
posit
control
bencard
brentford
middlesex
uk
atop
individu
defin
least
two
posit
test
mm
weal
respons
diluent
control
allergen
use
b
ige
measur
serum
ige
valu
determin
doubleantibodi
solidphas
elisa
enzygnost
ige
calbiochem
behr
corp
la
jolla
ca
usa
symptom
assess
subject
complet
valid
questionnair
daili
week
prior
week
hrv
infect
symptom
grade
accord
sever
criteria
cold
base
propos
jackson
et
al
clinic
ill
consid
present
volunt
minimum
cumul
symptom
score
period
subject
impress
cold
rhinorrhea
present
least
day
observ
baselin
rhinit
symptom
day
prior
inocul
subtract
new
cold
symptom
rhiniti
assess
either
absent
mild
sever
basi
histori
nasal
blockag
sneez
rhinorrhea
preced
year
recent
report
suggest
cold
symptom
influenc
alcohol
intak
subject
contact
intak
time
quantifi
averag
number
drink
per
day
nasal
lavag
nasal
wash
undertaken
instil
ml
prewarm
hank
balanc
salt
solut
hbss
gelatin
nostril
hold
expel
steril
petri
dish
sampl
aliquot
frozen
analys
albumin
measur
measur
code
sampl
done
rocket
immunoelectrophoresi
sensit
assay
gml
coeffici
variat
repeat
measur
nasal
inocul
viru
nasal
inocul
perform
instil
ml
hrv
suspens
kindli
suppli
dr
e
dick
w
buss
madison
wisconsin
usa
nostril
pipett
x
two
consecut
day
addit
spray
approxim
amount
nostril
atomis
de
vilbiss
co
heston
uk
use
handbulb
bulb
de
vilbiss
co
spray
coat
nasal
activ
confirm
viral
infect
nasal
wash
inocul
onto
ohio
hela
cell
cultur
hrv
shed
infect
diagnos
mean
typic
cpe
light
microscopi
cultur
examin
daili
regard
neg
show
cpe
two
pass
cell
cultur
presenc
viru
nasal
wash
determin
cultur
hela
cell
confirm
neutralis
hrv
specif
antiserum
atcc
cat
natl
inst
allergi
infect
di
bethesda
maryland
usa
posit
infect
establish
least
one
identifi
viral
isol
andor
fourfold
rise
titr
neutral
antibodi
quantif
viral
shed
difficult
score
system
viral
cultur
devis
day
lavag
collect
cpe
observ
hela
cultur
score
observ
summat
period
lavag
collect
maximum
cumul
score
statist
analysi
symptom
score
albumin
level
ige
level
subgroup
compar
mannwhitney
ttest
overal
differ
four
group
assess
kruskalw
oneway
anova
evalu
associ
symptom
score
age
albumin
ige
valu
employ
pearson
correl
test
associ
examin
use
spearman
rank
correl
test
consid
signific
total
volunt
initi
screen
presenc
serum
neutral
antibodi
antibodi
present
nine
deem
unsuit
person
reason
baselin
characterist
volunt
particip
studi
shown
tabl
group
consist
normal
subject
seven
femal
atop
individu
two
femal
six
asthma
differ
age
sex
distribut
note
atop
group
significantli
higher
ige
level
definit
clinic
cold
develop
subject
assess
symptom
score
neg
score
subject
normal
individu
howev
either
posit
viral
shed
cultur
signific
rise
neutral
antibodi
hrv
atop
volunt
clinic
cold
base
symptom
score
calcul
baselin
rhinit
symptom
subtract
two
subject
group
baselin
rhinit
score
taken
account
tabl
median
symptom
score
normal
subject
rang
rang
atop
volunt
comparison
score
significantli
differ
partli
result
high
score
normal
volunt
associ
found
age
symptom
score
cpe
score
chang
serolog
also
differ
note
alcohol
intak
normal
atop
volunt
influenc
symptom
score
present
viral
shed
cultur
posit
subject
although
low
cpe
score
record
one
subject
patient
median
cpe
score
normal
subject
eight
atopi
discrep
like
relat
differ
preinocul
antibodi
present
group
differ
note
group
measur
first
day
posit
cpe
median
number
day
viral
shed
data
shown
serolog
perform
month
actual
inocul
screen
subject
admiss
neutral
antibodi
titr
studi
repeat
baselin
serolog
day
inocul
yield
unexpect
result
normal
group
four
volunt
develop
increas
antibodi
dilut
less
atop
volunt
occur
six
individu
rise
greater
record
presenc
neutral
antibodi
concentr
equival
dilut
correl
absenc
chang
serolog
week
cold
case
patient
tabl
well
delay
viral
shed
median
cpe
score
first
day
sampl
cold
oppos
median
score
subject
latter
four
subject
also
tend
low
viral
cultur
cpe
score
tabl
median
cpe
score
calcul
vs
score
rest
group
take
preinocul
antibodi
account
normal
volunt
detect
antibodi
present
dilut
tend
mild
symptom
keep
lower
cultur
score
attenu
develop
neutral
antibodi
find
contrast
atop
individu
high
cold
symptom
score
correct
spite
ofth
presenc
preinocul
antibodi
low
cultur
score
mild
absent
serum
antibodi
respons
trend
normal
mild
sever
symptom
wherea
atopi
tend
sever
symptom
irrespect
preinocul
neutral
antibodi
statu
tabl
although
subgroup
small
differ
symptom
score
normal
atop
preinocul
antibodi
posit
individu
highli
signific
noteworthi
normal
volunt
absenc
antibodi
develop
sever
cold
case
tabl
level
ige
correl
symptom
score
viral
cpe
score
serolog
respons
nasal
wash
obtain
day
inocul
day
third
day
cold
result
albumin
measur
respect
day
shown
tabl
normal
subject
neutral
antibodi
present
median
decreas
nasal
wash
albumin
ugml
preinocul
antibodi
absent
normal
subject
develop
increas
nasal
albumin
median
increas
igml
cold
contrast
result
obtain
atop
group
spite
neutral
antibodi
present
atop
individu
develop
signific
increas
nasal
albumin
level
median
increas
yugmlp
vs
normal
differ
present
antibodi
neg
group
atop
vs
normal
p
normal
vs
atop
group
whole
p
grade
increas
nasal
albumin
chang
associ
cold
lowest
normal
antibodi
posit
individu
highest
atop
antibodi
neg
subject
confirm
increas
sensit
confer
atop
trait
signific
correl
found
ige
nasal
albumin
normal
r
atopi
r
ol
p
preinocul
antibodi
posit
subject
symptom
score
correl
nasal
albumin
r
antibodi
neg
individu
r
p
produc
experiment
hrv
infect
normal
atop
volunt
good
clinic
cold
induc
assess
symptom
score
infect
confirm
viral
shed
cultur
serolog
atop
individu
contrast
normal
volunt
tend
sever
cold
symptom
well
greater
increas
nasal
albumin
level
prevent
preinocul
neutral
antibodi
high
ige
level
correl
sever
clinic
diseas
histor
induct
experiment
infecti
diseas
volunt
initi
permit
explor
variou
infecti
epidemiolog
pathogenet
aspect
control
condit
human
model
particularli
use
investig
viral
diseas
help
clarifi
transmiss
diseas
pattern
mani
respiratori
virus
includ
rhinovirus
recent
attent
focus
interact
diseas
asthma
bronchiectasi
respiratori
virus
studi
examin
role
either
direct
causat
exacerb
preexist
diseas
experiment
hrv
diseas
past
involv
group
normal
volunt
studi
viral
transmiss
antibodi
respons
studi
report
data
obtain
patient
subgroup
particular
risk
respiratori
complic
atopi
asthmat
doyl
et
al
found
evid
support
increas
suscept
atop
individu
hrv
spite
batteri
sophist
sensit
investig
past
experiment
hrv
cold
often
induc
instil
viruscontain
drop
pipett
nose
aerosol
virus
may
induc
cold
reliabl
recent
studi
suggest
use
atomis
releas
fine
spray
may
mimic
natur
occur
hrv
transmiss
better
employ
method
coupl
rel
high
inocul
titr
viru
method
yield
high
infect
rate
assess
viral
shed
seroconvers
high
percentag
subject
develop
clinic
cold
measur
symptom
score
atop
volunt
tend
moder
sever
cold
irrespect
preinocul
neutral
antibodi
contrast
normal
subject
mild
symptom
preinocul
antibodi
excess
dilut
demonstr
rel
subject
observ
support
chang
nasal
wash
albumin
level
found
cold
naclerio
et
al
found
good
correl
intens
cold
symptom
albumin
level
nose
employ
measur
obtain
object
paramet
sever
group
volunt
albumin
influx
repres
passiv
transud
plasma
like
reflect
degre
nasal
mucos
inflamm
associ
clinic
cold
symptom
chang
albumin
level
cold
significantli
higher
atop
subject
neutral
antibodi
present
compar
normal
individu
tabl
largest
chang
albumin
level
note
atop
antibodi
neg
volunt
total
group
compar
irrespect
preinocul
antibodi
differ
note
either
symptom
score
albumin
level
result
suggest
presenc
absenc
neutral
antibodi
primari
determin
host
clinic
respons
hrv
cold
overrid
effect
atopi
conceal
infiuenc
comparison
rel
sever
diseas
normal
antibodi
neg
individu
howev
antibodi
neg
normal
atop
group
exclud
analysi
increas
sensit
atopi
subjeet
becom
obviou
exclud
identifi
preexist
rhinit
symptom
howev
baselin
symptom
present
subtract
adjust
final
score
furthermor
two
atop
subject
subgroup
histori
atop
rhiniti
symptom
score
corrobor
chang
nasal
albumin
level
data
correspond
find
doyl
et
al
subject
studi
antibodi
neg
screen
reason
outlin
differ
atop
normal
individu
would
appar
unless
stratif
possibl
posit
neg
preinocul
antibodi
level
although
studi
also
tri
compar
sever
found
differ
studi
design
method
compar
studi
support
result
studi
experiment
coronaviru
infect
suggest
atopi
may
relat
sever
cold
symptom
associ
also
found
clinic
cold
score
nasal
serum
ige
concentr
discrep
absent
initi
h
rv
neutral
antibodi
level
low
titr
day
prior
inocul
unexpect
repeat
measur
neutral
antibodi
titr
sampl
within
one
doubl
dilut
assay
alway
perform
duplic
consist
result
duplic
experi
minor
variabl
repeat
assay
technic
factor
unlik
explain
chang
possibl
reason
may
develop
crossreact
neutral
antibodi
respons
hrv
cold
caus
serotyp
phenomenon
report
antibodi
crossreact
relationship
demonstr
hrv
la
heterotyp
serotyp
although
bave
definit
evid
surmis
major
volunt
develop
hrvassoci
cold
interim
period
inocul
develop
neutral
antibodi
crossreact
hrv
previou
inocul
studi
report
similar
lack
serolog
respons
cold
presenc
neutral
antibodi
level
equal
exceed
dilut
demonstr
studi
low
level
antibodi
prevent
develop
infect
normal
atop
volunt
probabl
result
rel
high
dose
viru
use
inocul
associ
found
age
sex
variou
paramet
infect
find
similar
earlier
report
role
high
ige
serum
level
marker
increas
suscept
rhinovir
diseas
evalu
although
data
limit
number
subject
suggest
greater
suscept
atop
individu
defin
skin
test
sever
symptom
nasal
albumin
level
correl
ige
level
tissu
event
may
parallel
serum
marker
serum
ige
may
thu
reflect
level
ige
atopyassoci
mediat
nasal
tissu
altern
although
symptom
score
employ
sensit
detect
cold
may
rel
insensit
presenc
sever
symptom
suitabl
discrimin
moder
sever
sever
cold
lack
distinct
natur
hamper
correl
sought
ige
level
atop
individu
may
therefor
exhibit
increas
sensit
consequ
common
cold
prompt
suggest
allerg
tissu
preprim
exist
allerg
diseas
although
mediat
involv
cold
symptom
defin
specul
quantiti
variou
cytokin
exampl
gmcsf
well
inflammatori
mediat
leukotrien
kinin
may
amplifi
atop
tissu
caus
sever
symptom
releas
kinin
potent
vasoact
peptid
identifi
nasal
secret
cold
caus
vasodil
increas
vascular
permeabl
probabl
gener
nose
cold
addit
intercellular
adhes
cellular
receptor
major
group
hrv
may
upregul
allerg
inflamm
atop
individu
may
predispos
higher
rate
hrv
infect
even
increas
accompani
nasal
recruit
mediat
cell
abl
amplifi
exist
inflamm
summari
studi
employ
experiment
hrv
diseas
programm
normal
atop
volunt
yield
signific
upper
airway
cold
symptom
greater
sever
atop
group
util
similar
protocol
allow
clarif
ofth
oper
pathophysiolog
mechan
relationship
atopi
asthma
